Primary breast tumors from BRCA1 mutation carriers have unique pathology, including high histological grade, atypical medullary histotype, high rates of cellular proliferation, pushing margins and infiltrating lymphocytes, and are frequently ER, PR, and HER2 negative (triple negative) [29]. The gene discussed is BRCA1; the disease is breast neoplasm.